Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA.

  title={Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA.},
  author={Scott D Doughman and Srirama Krupanidhi and Carani B. Sanjeevi},
  journal={Current diabetes reviews},
  volume={3 3},
Long-chain EPA/DHA omega-3 fatty acid supplementation can be co-preventative and co-therapeutic. Current research suggests increasing accumulated long chain omega-3s for health benefits and as natural medicine in several major diseases. But many believe plant omega-3 sources are nutritionally and therapeutically equivalent to the EPA/DHA omega-3 in fish oil. Although healthy, precursor ALA bio-conversion to EPA is inefficient and production of DHA is nearly absent, limiting the protective value… 

Tables from this paper

Alternative Sources of Omega-3 Fats: Can We Find a Sustainable Substitute for Fish?
The recent research for developing prospective substitutes for omega-3 PUFA and the current limitations that are faced are summarised.
How do algae oils change the omega-3 polyunsaturated fatty acids market?
The health benefits of a diet rich in omega-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA) no longer need to be proven. However, while health authorities attempt to increase the consumption
Algae Oil, a Valuable Source of Long Chain Polyunsaturated Fatty Acids
Omega-3 rich diets have showed multiple positive effects in clinical and nutritional studies, and marine and freshwater eukaryotic microorganism, autotrophic and heterotrophic, showed interesting yields and are good candidates to launch an industrial bioprocess.
A novel bioactivity of omega-3 polyunsaturated fatty acids and their ester derivatives.
It is suggested that n-3 PUFA could have a positive therapeutic effect for improving oral health via their antibacterial activities, besides their anti-inflammatory effects.
Seafood lipids and cardiovascular health
Consumption of large amounts of n-3 PUFA exerts a positive effect on a wide array of cardiovascular health concerns ranging from hypertension and atherosclerosis to myocardial infarction and stroke.
Microalgae n-3 PUFAs Production and Use in Food and Feed Industries
This work aims to define better the issues surrounding n-3 PUFA production and supply and the potential of microalgae as a sustainable source of compounds to enhance the food and feed of the future.
Engineering of EPA/DHA omega-3 fatty acid production by Lactococcus lactis subsp. cremoris MG1363
The findings advance the future use of EPA/DHA-producing lactic acid bacteria in such applications as dairy starters, silage adjuncts, and animal feed supplements.
What are Omega-3 Fatty Acids and Where Can I Find Them? Omega-3 fatty acids are polyunsaturated fatty acids and consist of eicosapentaenoic acid
    Omega-3 fatty acids are polyunsaturated fatty acids and consist of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid Omega-3 is an essential fatty acid (EFA) that must


    Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids.
    BACKGROUND For many persons who wish to obtain the health benefits provided by dietary n-3 fatty acids, daily ingestion of fish or fish oil is not a sustainable long-term approach. To increase the
    Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications.
    Total n-3 requirements may be higher for vegetarians than for nonvegetarians, as vegetarians must rely on conversion of ALA to EPA and DHA, although the response is generally less for ALA than for EPA andDHA.
    Dietary n-6 and n-3 fatty acid balance and cardiovascular health.
    Epidemiological and clinical studies have established that the n-6 fatty acid, linoleic acid (LA), and the n-3 fatty acids, linolenic acid (LNA), eicosapentaenoic acid (EPA), and docosahexaenoic acid
    Omega 3 fatty acids and cardiovascular disease—fishing for a natural treatment
    The current evidence regarding fish oils and cardiovascular disease, their possible mechanism of action, and potential future developments and research strategies are reviewed.
    Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial.
    Triacylglycerol (TG) lowering effects of n-3 long-chain PUFA (n-3 LCPUFA) have been repeatedly demonstrated, but studies investigating the individual effects of EPA or DHA on plasma TG and
    Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women
    DHA supplementation at a dose of 2.14 g/day for 42 days decreases plasma cholesterol but neither does it show beneficial effects on estrogen metabolism, nor does it induce deleterious effects on the observed in vivo antioxidant or oxidative stress marker in postmenopausal vegetarian women.
    Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6n-3) and docosapentaenoic acid (22:5n-6) on cardiovascular risk factors in healthy men and women
    The oil was well tolerated and did not adversely affect cardiovascular risk, and Factor VII (FVII) coagulant activity increased by 12% following active treatment.
    Dietary n-3 fatty acid intake and risk of sudden death and coronary artery disease
    • C. Albert
    • Medicine
      Current treatment options in cardiovascular medicine
    • 2007
    Opinion statementBased upon the data from observational epidemiologic studies and randomized clinical trials that are summarized in this article, as well as plausible mechanisms for benefit, the
    Distribution, interconversion, and dose response of n-3 fatty acids in humans.
    It is concluded that the most predictable way to increase a specific long-chain n-3 fatty acid in plasma, tissues, or human milk is to supplement with the fatty acid of interest.